Convertible Announced
Imugene equity raising
A$20m raised
Announced 11 Mar 2026 · ASX: IMU · A$0.18 cash per share
Advisers
Imugene
Issuer
- Legal adviser
Lead managers
Not disclosed
- Issuer
- Imugene
- Sector
- Biotech and pharmaceuticals
Similar deals
- Imugene placement Jul 2025 · A$22.5m · Biotech and pharmaceuticals
- Actinogen Medical placement Feb 2026 · A$17m · Biotech and pharmaceuticals
- Neurizon Therapeutics placement Dec 2025 · A$24.2m · Biotech and pharmaceuticals
- Recce Pharmaceuticals entitlement offer Jun 2025 · A$15.8m · Biotech and pharmaceuticals
- Arovella Therapeutics placement Feb 2025 · A$15m · Biotech and pharmaceuticals
Sources
- 11 Mar 2026 $20M placement and SPP, convertible notes amended ASX
- 24 Mar 2026 $20M Capital Raising and Convertible Notes Issue mccullough.com.au